pyrimethamine has been researched along with Cerebromalacia in 1 studies
Maloprim: contains above 2 cpds
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten (91%) of these 11 patients with recurrence showed focal persistent enhancement after the initial treatment of toxoplasmosis abscess." | 1.29 | Persistent enhancement after treatment for cerebral toxoplasmosis in patients with AIDS: predictive value for subsequent recurrence. ( Benmelha, Z; Bouvet, E; Casalino, E; Laissy, JP; Lariven, S; Parlier, C; Servois, V; Sibert, A; Soyer, P; Vachon, F, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laissy, JP | 1 |
| Soyer, P | 1 |
| Parlier, C | 1 |
| Lariven, S | 1 |
| Benmelha, Z | 1 |
| Servois, V | 1 |
| Casalino, E | 1 |
| Bouvet, E | 1 |
| Sibert, A | 1 |
| Vachon, F | 1 |
1 other study available for pyrimethamine and Cerebromalacia
| Article | Year |
|---|---|
Persistent enhancement after treatment for cerebral toxoplasmosis in patients with AIDS: predictive value for subsequent recurrence.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Atrophy; Brain; Brain Abscess; Drug Therapy, Com | 1994 |